Corrective cosmetics are effective for women with facial pigmentary disorders

Cutis

Volumn 75, Issue 3, 2005, Pages 181-187

  Balkrishnan, Rajesh ^a,b   McMichael, Amy J ^a,d   Hu, Judy Y ^a   Camacho, Fabian T ^a   Kaur, Mandeep ^a   Bouloc, Anne ^c,e   Rapp, Stephen R ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Tarnier Hospital   (France)

^d Galderma Laboratories   (United States)

^e Vichy Laboratories   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COSMETIC;

ACNE; ADULT; ARTICLE; CHLOASMA; FACE INJURY; FEMALE; FOLLOW UP; HUMAN; HYPOPIGMENTATION; LENTIGINOSIS; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; PAPULOSIS; PIGMENT DISORDER; ROSACEA; SKIN DISEASE; SKIN SCAR;

ADULT; COSMETICS; FACIAL DERMATOSES; FEMALE; HUMANS; MIDDLE AGED; PIGMENTATION DISORDERS;

EID: 17144401851     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Roberts NC. Corrective cosmetics-need, evaluation and use. Cutis. 1988;41:439-441.
2. Chren MM, Lasek RJ, Sahay AP, et al. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001;5:105-110.
3. Chren MM, Lasek RJ, Quinn LM, et al. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996;107:707-713.
4. Dixon JA, Rotering RH, Huether SE. Patient's evaluation of argon laser therapy of port wine stain, decorative tattoo, and essential telangiectasia. Lasers Surg Med. 1984;4:181-190.
5. Lanigan S, Cotterill JA. Psychological disabilities amongst patients with port wine stains. Br J Dermatol. 1989;121:209-215.
6. Lanigan S. The stigma of port wine stains. Br J Hosp Med. 1991;45:274-276.
7. Porter J, Beuf AH, Lerner A, et al. Psychosocial effect of vitiligo: a comparison of vitiligo patients with "normal" control subjects, with psoriasis patients, and with patients with other pigmentary disorders. J Am Acad Dermatol 1986;15:220-224.
8. Porter J, Beuf A, Nordlund JJ, et al. Personal responses of patients to vitiligo: the importance of the patient-physician interaction. Arch Dermatol 1978;114:1384-1385.
9. Porter J, Beuf AH, Lerner A, et al. Response to cosmetic disfigurement: patients with vitiligo. Cutis. 1987;39:493-494.
10. Porter J, Beuf AH, Lerner A, et al. The effect of vitiligo on sexual relationships. J Am Acad Dermatol 1990;22:221-222.
11. Kanzaki J, Ohshiro K, Abe T. Effect of corrective make-up training on patients with facial nerve paralysis. Ear Nose Throat J. 1998;77:270-274.
12. Draelos ZK. Cosmetic camouflaging techniques. Cutis. 1993;52:362-364.
13. Kimbrough-Green CK, Griffiths CE, Finkel LJ, et al. Topical retinoic acid (tretinoin) for melasma in black patients. a vehicle-controlled clinical trial. Arch Dermatol. 1994;130:727-733.
14. Leary MR, Rapp SR, Herbst KC, et al. Interpersonal concerns and psychological difficulties of psoriasis patients: effects of disease severity and fear of negative evaluation. Health Psychol. 1998;17:530-536.
15. Rapp SR, Cottrell CA, Leary MR. Social coping strategies associated with quality of life decrements among psoriasis patients. Br J Dermatol. 2001;145:610-616.
16. Balkrishnan R, McMichael AJ, Camacho FT, et al. Development and validation of a health-related quality of life measurement for use in women with melasma. Br J Dermatol 2003;149:572-577.
17. Greene WH. Econometric Analysis. 3rd ed. Englewood Cliffs, NJ: Prentice Hall; 1998.
18. StatCorp. Statistical Software: Release 5.0. College Station, Tex: Stata Corporation; 1997.